Skip to main content
Press Release

Pharmacist Convicted of Unlawfully Distributing Controlled Substances

For Immediate Release
Office of Public Affairs

A federal jury in the Southern District of Texas convicted a Texas pharmacist on May 27 for unlawfully distributing controlled substances from a now-shuttered Houston pharmacy.

According to court documents and evidence presented at trial, Hieu “Tom” Truong, 58, of Houston, was the pharmacist-in-charge of S&S Pharmacy in Houston. In just 18 months, Truong and his co-conspirators unlawfully distributed over 750,000 doses of controlled substances, including over 500,000 oxycodone and hydrocodone pills. Trial evidence showed that S&S Pharmacy unlawfully dispensed controlled substances in bulk for cash, based on forged or stolen prescriptions brought in by street-level drug dealers.

Truong was convicted of three counts of unlawfully distributing and dispensing controlled substances. He faces a maximum penalty of up to 20 years in prison on each count. A federal district court judge will determine any sentence after considering the U.S. Sentencing Guidelines and other statutory factors. Sentencing is scheduled for Oct. 3.

To date, seven other co-conspirators, including the owner and manager of the pharmacy, have pleaded guilty to unlawfully distributing controlled substances.

Assistant Attorney General Kenneth A. Polite, Jr. of the Justice Department’s Criminal Division; U.S. Attorney Jennifer Lowery for the Southern District of Texas; and Special Agent in Charge Daniel C. Comeaux of the Drug Enforcement Administration’s (DEA) Houston Division made the announcement.

DEA Houston investigated the case, with assistance from the Conroe Police Department, Houston Police Department, and Harris County Constables Office.

Trial Attorneys Devon Helfmeyer, Courtney Chester, and Andrew Tamayo of the Criminal Division’s Fraud Section are prosecuting the case, and Assistant U.S. Attorney Kristine Rollinson for the Southern District of Texas is handling forfeiture.

Updated May 31, 2022

Topic
Opioids
Press Release Number: 22-575